Roger Pomerantz Insider Trading $RUBY Rubius Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Roger Pomerantz.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Roger Pomerantz. Roger Pomerantz is Director in Viracta Therapeutics, Inc. ($SNSS) and Chief Executive Officer in CONTRAFECT Corp ($CFRX) and Director in CONTRAFECT Corp ($CFRX) and Director in Seres Therapeutics, Inc. ($MCRB) and President and CEO in Seres Therapeutics, Inc. ($MCRB) and Director in Intec Pharma Ltd. ($NTEC) and Director in Rubius Therapeutics, Inc. ($RUBY).

Roger Pomerantz in Rubius Therapeutics, Inc.

Trading Symbol: RUBY
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Roger Pomerantz: Director
Holdings: 100 shares
Latest Transaction: Jul 23 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Roger Pomerantz in Rubius Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CFRX, NTEC, RUBY, MCRB, SNSS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 23 2018RUBYRubius Therapeutic ...Pomerantz RogerDirectorBuyP23.001002,3001000 to 100
Jul 18 2018RUBYRubius Therapeutic ...Pomerantz RogerDirectorOption ExerciseA23.0025,000575,00025,000

Page:   1